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Autoantibodies against native DNA have been found in sera 
of patients with autoimmune disorders, particularly with 
systemic lupus erythematosus (SLE). Experimental induction of 
anti-DNA autoantibodies has not been successful but the 
production of antibodies against m.odified forms of native DNA 
and its synthetic analogues have been successfully carried out. 
Apart from the various structures acting as a trigger for 
autoantibodies in SLE, the intracellular and secreted 
mycobacterial protein antigens have been found to possibly act 
as potential triggers for autoantibody production. 
In the present study attempts were made to probe the 
possible involvement of the mycobacterial protein antigens in 
the autoantibody induction. The secreted mycobacterial protein 
antigens were isolated from the Mycobacterium tuberculosis 
H37RV strain. The 5-20% gradient SDS-PAGE showed a wide 
spectrum of protein antigens ranging from very low to high 
molecular weight. The immunointeraction of these protein 
antigens with SLE autoantibodies was investigated by means of 
Enzyme linked immunosorbent assay. Dot blot assay and Western 
blotting. The anti-DNA antibodies recognized appreciably these 
mycobacterial antigens as detected by direct binding and Dot 
blot assay. As revealed by inhibition results, a binding of 
greater magnitude was observed for SLE autoantibodies with the 
secreted mycobacterial proteins (MTCF) when compared with that 
of native dsDNA. Competition ELISA results indicated the 
specificity of naturally occurring anti-DNA antibodies in the 
order of MTCF > ssDNA > dsDNA > RNA. The major immunodominant 
secretory protein in the MTCF, the antigen 85 complex, of 
molecular weights 30 kDa and 31 kDa were fractionated by 
employing Sephadex G-200 column chromatography. The binding of 
antigen 85 complex was probed with the immunoaffinity purified 
SLE IgG on a DNA-[polylysyl-Sepharose 4B] column. The 
interaction analysis in western blotting exhibited a strong 
recognition of affinity purified SLE IgG by the antigen 85 
complex. It could thus be inferred from the above studies that 
the mycobacterial protein antigens may possibly trigger the 
production of circulating autoantibodies cross reacting with 
native DNA. 
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The exact origin or trigger of autoantibodies in autoimmune 
disorders, particularly in systemic lupus erythematosus (SLE) 
still remains to be answered (Stollar, 1989). Various cellular 
antigens apart from native double stranded DNA (dsDNA) have been 
found to recognize SLE autoantibodies (Stollar, 1975). Native 
DNA as such, is known to be a poor immunogen. Thus it appears 
that dsDNA might only be a cross-reacting antigen whereas 
some other structure(s) might be acting as the trigger for 
autoantibody production (Steinberg, 1992). The possible 
association of Mycobacterium tuberculosis and human autoimmune 
disease have been indicated (Jarjour et al., 1991; Young, 1992), 
but their role in its pathogenesis is not yet clear. Recent 
studies indicate the possible involvement of some mycobacterial 
antigens in autoantibody induction (Norten et al., 1989; Cohen 
and Young, 1991; Winfield and Jarjour, 1991). 
Extension of our knowledge of immune responses after 
mycobacterial infections, their significance, and development of 
new methods for the diagnosis and prevention of these 
infections depend on work with isolated immunogenic components 
of the bacilli. In many instances, particularly with regard to 
cell mediated immune responses, these components are required 
for d€Jtailed characterisation of the specificity of immune 
responses. Many observations also indicate that isolated 
components are essential in basic studies for developing 
improved methods of vaccination against mycobacterial diseases. 
Growing bacteria release a wide spectrum of proteins into their 
surroundings. These secreted proteins (ranging from very low to 
high molecular weights) are widely suggested as protective 
antigens, responsible for rapid recognition of bacilli by host 
lymphocytes. This hypothesis was supported by the finding that 
whereas immunization with live bacilli efficiently generated 
protective T lymphocytes, killed preparations did not. Recently 
this theory has been supported with the observation of a strong 
correlation between bacterial multiplication in the host and T-
cell reactivity against secreted proteins. 
Mycobacteriiim 
The genus Mycobacterium comprises the 'acid fast bacilli' 
and are classified into two groups : 
(1) the typical tubercle bacilli - Mycobacterium tuberculosis as 
well as Mycobacterium bovis. and 
(2) the atypical mycobacteria, including commensal, saprophytic 
and opportunistically pathogenic species - tuberculoid and 
leprosy bacilli. 
Culture Characters 
The tubercle bacillus is an obligate aerobe and grows 
optimally at 35-37°C. The generation time in vitro is 14-15 
hours. The solid Lowenstein - Jensen (LJ) medium is most widely 
employed for routine culture while the liquid medium (Sauton's 
medium) is mostly used for sensitivity as well as chemical 
tests and preparation of antigens and vaccines. Diffuse growth 
is obtaiined in medium containing a Tween-80 detergent (sorbitan 
mono-oleate). In an effort to avoid the problem of smaller 
yields of protein antigen with contaminating lytic products and 
irrelevant polysaccharide, virulent Mycobacterium tuberculosis 
cultures were harvested during the mid-logarithmic growth phase 
(Turcotte and DesOrmeaux, 1972). 
Immunological Studies in Tuberculosis 
Tubercle bacilli do not possess any products (capsules or 
toxins) that can be correlated with their capacity to produce 
disease. This capacity depends solely upon their ability to 
multiply inside the host tissue, especially the macrophages, 
where they withstand host defence mechanism and utilize the 
host tissue material for their own growth. Acquired immunity in 
tuberculosis is of cellular type since tubercle bacilli are 
intracellular parasites. Both delayed hypersensitivity and cell 
mediated immunity play a role in antibacterial mechanism in 
tuberculosis and they are mediated by lymphokines. Macrophage 
migration inhibitory factor (MIF) was detected during delayed 
hypersensitivity.' The standard tuberculin skin test method of 
detecting Mycobacterium tuberculosis infection, actually measures 
the host cellular immune response to the mycobacterium and it is 
the mycobacterial components that are important in eliciting the 
cellular immune response. Mycobacteria are known to be the 
most important class of intracellular parasites that have been 
the scourge of mankind since the earliest days of recorded 
history. The most prominent site for their attack are the 
monocytic cells, and in susceptible individuals cause chronic 
inflammation and progressive scarring. 
Acquired resistance seems to be induced by protein antigens 
carried by antigen - presenting cells to the draining lymph 
node(s) from the developing tubercle (Collins, 1991). Some of 
these proteins are intimately associated with the bacterial cell 
wall (Brennan, 1989), whereas others seem to be released by the 
actively growing bacilli within the phagocytic cell (Collins 
et al. , 1988). Some of these immunogenic proteins (or their 
genes) bear a close homology to the so called shock proteins 
released by both eukaryotic and prokaryotic cells when subjected 
to various forms of stress (Young et al., 1990). These stress 
proteins trigger the protective cell-mediated immune response 
within the infected host (Young, 1988). Some antigens (for 
example, the 65 KDa heat - shock protein) appear to be 
immunodominant and some may induce undesirable (suppressive) 
cellular responses that are responsible for the prolonged 
carrier state that is characteristic of tuberculosis. The 
homology (cross-reactivity) between these mycobacterial antigens 
and heat stress proteins may possible be responsible for the 
autoimmune responses seen in some patients with tuberculosis 
whose T cells respond strongly to these mycobacterial proteins 
in vivo (Young et al., 1988) . 
Mycobacteria and Autoimmunity 
.An antibody response against epitopes cross reactive between 
bacterium and host is interpreted as the autoimmune response. 
Recent data have suggested a role for mycobacteria, or 
autoantigens cross-reactive with mycobacteria, in the aetiology 
of autoimmune diseases, particularly systemic lupus erythematosus 
(SLE). Mycobacterial antigens, mostly heat shock proteins (hsp) 
are extremely potent adjuvants for the induction of polyclonal B 
cell activation. The production of antibodies specific to 
epitopes present on prokaryotic hsp appears to cross react with 
the human hsp. Hypergammaglobulinemia is associated with active 
tuberculosis, and patients with pulmonary tuberculosis develop 
rheumatoid factor and many of the same antinuclear autoantibodies 
characteristic of patients with SLE. Some murine and human 
monoclonal antibodies to DNA bind to mycobacteria; conversely, 
some monoclonal antibodies to mycobacteria bind to DNA (and 
express the 16/6 anti-DNA idiotype). Persistent arthritis has 
been reported in patients given BCG immunotherapy. Collectively, 
such observations are consistent with the concept of molecular 
mimicry (Oldstone, 1987) between mycobacterial antigens and host 
constituents in the genesis of some forms of autoimmunity. 
Besides bacterial carbohydrate and lipid antigens, certain 
evidence suggests a contribution by stress proteins as well. 
The high degree of homology between human and mycobacterial 
65 KDa hsp makes this protein a very strong candidate for 
potential autoreactivity through 'mimicry'. T cells responding 
to the 65 Kda mycobacterial hsp cross-reacted with the 
'unrelated' proteoglycan core protein (Holoshitz et al., 1986) . 
This implies that 'mimicked' amino acid sequences on other 
autoantigens can also be the target of the mycobacterial 
65 KDa cellular response. IgG antibodies to hsp90 as well as to 
the 73 KDa member of the hsp70 family are present, in SLE 
patients (Minota et al., 1988a and b). The anti-hsp70 antibodies 
are restricted to the constitutively expressed 73 KDa member 
of this family and cross react with a peptide binding protein in 
the mouse which plays a role in antigen presentation (Lakey et 
al., 1987; Van et al., 1989). 
Heat Shock Proteins 
The cloning and sequencing of genes coding for major 
mycobacterial protein antigens revealed that most of these 
proteins are members of stress protein (or heat shock protein) 
families (Young et al., 1988). These stress proteins occur in 
highly conserved forms in all organisms, from bacteria to 
man (Lindguist and Craig, 1988) . A variety of T cell types 
isolated from healthy individuals can recognize one's own 
stress proteins. This observation, and the finding that viral 
and bacterial infections can induce stress responses in host 
cells has led to the hypothesis that some anti-stress protein T 
lymphocytes are involved in immune surveillance of autologous 
cells. If such surveillance mechanism exists, then occasional 
overstimulation of immune cells, perhaps by infection, might lead 
to autoimmune disease. Indeed, autoimmune responses to stress 
proteins have been implicated in rheumatoid arthritis and in 
insulin-dependent diabetes. It is now widely recognized that 
heat shock proteins are potent inducers of both humoral and cell 
mediated immune responses involving multiple lymphocyte subsets 
in the range of infectious to autoimmune diseases. 
Immunization of mice with whole cell lysates from 
Mycobacterium tuberculosis elicits antibody responses to only a 
limited set of protein antigens suggesting that these • antigens 
are major targets of the immune response. Gene cloning and 
sequence analysis revealed that several of these protein 
antigens are counterparts of well known stress proteins. These 
include HSP70 (dnak), the 65 KDa 'common antigen' (a homolog of 
the E. coli groEL product, HSP60) and a 12 KDa species that is 
homologous to the E.coli groES product. Epitope mapping on 
HSP60 proteins indicates that antibodies and T cells can 
recognize many different portions of the molecule (Mehra et al., 
1986; Lamb et al., 1987; Thole et al., 1988; Lamb and Young, 
1989). Thus, the entire HSP60 protein can be involved in immune 
responses; no one single epitope is dominant. HSP60 appears 
to be a general target of the immune system in bacterial 
infections including leprosy and tuberculosis (Young et al., 
1988), lyme disease (Hansen et al., 1988), Q fever (Vodkin 
and Williams, 1988), syphilis (Hindersson et al., 1987), 
legionellosis (Plikaytis et al., 1987) and binding trachoma 
(Morrison et al., 1989). 
The T lymphocytes that have been demonstrated to be capable 
of self stress protein recognition include 004"^CDS", cL/'^ T cell 
receptor-bearing cells (Lamb et al.,1989; Munk et al., 1989). 
These 'helper' cells produce lymphokines that can stimulate B 
cells to produce antibodies and can provoke cytotoxic T 
lymphocytes to more effectively kill their cytotoxic cells. 
Cytotoxic T cells that are CD4" CDS"*" and have o^ /^  receptors have 
also been identified that recognize stress proteins (Koga et 
al., 1989). These cells appear to be able to kill autologous 
cells that express the stress protein antigen on their surface. 
In addition, foreign or self HSP60 protein is also recognized by 
a class of T lymphocytes expressing i /£ T cell receptor 
(Haregewoin et al., 1989; Holoshitz et al., 1989; Modlin et al., 
1989; 0' Brien et al, 1989). Furthermore, T cells are also 
capable of cytolysing the target cells expressing HSP60. Koga 
et al. (1989) have shown that bone marrow derived macrophages 
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are killed by CDS"^  cytotoxic T cells. These T cells are 
specific for mycobacterial HSP60 when macrophages are stressed 
by cytomegalovirus infection, by heat shock or by exposure to 
IFN-f treatment. These data support the hypothesis that HSP60 
specific T cells can recognize and kill stressed autologous 
cells. However, in autoimmune diseases, if they are a consequence 
of stress protein recognition, may represent cases in which 
overstimulation of the immune response to stress protein has 
occured or where regulation of the immune response to stress 
protein has broken down. 
Antigenic properties 
Great efforts have been made in recent years to purify 
protein antigens from either mycobacterial cell extracts or 
culture filtrates (Daniel and Anderson, 1978; Daniel and 
Janicki, 1978; Nagai et al., 1981; Yano et al., 1984; Harboe et 
al., 1986) . Isolated and well characterized antigens are of use 
as species-specific immunologically active antigens for 
diagnostic purposes (Daniel et al., 1982) and in the follow up 
of the immunological response accompanying the pathological 
events of mycobacterial infections. The principal immunological 
response in tuberculosis is the development of cell mediated 
immunity, which becomes detectable a few weeks after natural 
infection or BCG vaccination. It is demonstrated by the delayed 
hypersensitivity reaction which follows the intradermal 
inoculation of tuberculin, a preparation of protein antigens 
extracted from tubercle bacilli. In the Mantoux test which is 
most widely used, a test dose of tuberculin containing 5 
Tuberculin Units (ITU, equivalent to 0.01 mg Old Tuberculin or 
0.002 ug Purified Protein Derivative) is injected intradermally 
on the forearm. A positive reaction is indicated by oedema 
and induration greater than 10mm in diameter at the site examined 
after 72 hours. 
The i^tigen 85 Complex 
The group of secreted proteins is of great interest in 
relation to the immune response to infection since these proteins 
are candidates of particular importance for development of 
protective immunity as well as clinical symptoms and 
complications of the disease. Quantification of the components 
in culture fluids and bacterial sonic extracts shows that the 
proteins of the antigen 85 complex are major secretion products 
of Mycobacterium tuberculosis and Mycobacterium bovis BCG 
(Fukui et al., 1965; Closs et al., 1980; Wiker et al., 1986 and 
1988; Abou-Zeid et al., 1988). They constitute more than 30% 
of the total protein of the secreted antigens. According to the 
nomenclature of mycobacterial antigens, the term MPB introduced 
by Nagai et al. (1981) designate a protein purified from M. 
bovis BCG. The corresponding term MPT denote a protein isolated 
from M. tuberculosis. The antigen 85 complex consists of three 
internally cross-reacting antigens encoded by three genes 
located at separate sites in the mycobacterial genome (Wiker et 
al., 1990; Content et al., 1991). The three antigens of 85 
complex were found to be heterogenous with regard to 
electrophoretic mobility, molecular weight (MW), hydrophobic and 
immunological properties. They were designated A, B and C in 
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increasing order, according to their electrophoretic mobilities. 
The molecular weight of antigens 85A, 85B and 85C were found to 
be 31 KDa, 30 KDa, and 31.5 KDa respectively as determined by 
SDS-PAGE. The purified M. tuberculosis alpha antigen (Tasaka et 
al., 1983) and the antigen 6 of the U.S. Japan reference system 
in Immunoelectrophoresis (Janicki et al., 1971) identifies with 
antigen 85B. The P32 antigen purified from BCG identifies 
with the antigen 85A (De Bruyn et al., 1987). In Nagai's' 
terminology, MPT44/MPB44, MPT59/MPB59, and MPT45/MPB45 correspond 
to antigens 85A, 85B, and 85C, respectively. Of the components 
in the antigen 85 complex, 85A and 85B are the best 
characterized so far. The partial identity between these two 
components was observed through CIE and confirmed by double 
diffusion experiments using different antisera. 
Cross-reactive Epitopes of Antigen 85 Complex 
The crossreactive epitopes of antigen 85 complex has been 
found in all mycobacterial species so far by double diffusion 
precipitation tests (Daniel and de Muth, 1977; Tasaka et al., 
1983; Tasaka and Matsuo, 1984; Tasaka et al., 1985), CIE 
(Harboe et al., 1979), ELISA (Wiker et al., 1990) and western 
blotting (Andersen et al., 1986; Drowart et al., 1992). Species 
specific epitopes have been found on crossreactive antigen 85 
complejx from several mycobacterial species (Tasaka and Matsuo, 
1984; Tasaka et al., 1985). Different monoclonal antibodies to 
antigen 85 complex of M. tuberculosis and BCG show a striking 
variation in reaction patterns when tested with other species of 
mycobacteria (Drowart et al., 1992). The monoclonal antibody 
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HYT27 reacts with two closely situated bands of about 30 KDa and 
31 KDa (Schou et al., 1985; Andersen et al., 1986; Abou-Zeid et 
al., 1988). These two bands corresponded to antigens 85B and 
85A. Furthermore, HYT27 reacts with the 85C component, 
coprecipitating with anti-BCG85 antibodies in CIE. These 
observations confirm that all three components of the antigen 85 
complex are closely related. 
Localization of Antigen 85 
Proteins and other components of bacteria are differentialy 
localized in the bacterial cell. Some components are soluble 
constituents of the cytosol, some are bound to the cytoplasmic 
membrane, while others are associated with the cell wall. Still, 
other proteins are actively secreted and released, and are only 
transiently present in cell compartments. The antigen 85 
complex is the major secreted constituent of mycobacterial 
culture fluids (Fukui et al., 1965) and the quantitatively 
dominating components are the antigens 85A and 85B which 
constitutes about 60% of total protein. Binding of human 
fibronectin to 85A and 85B components of the antigen 85 
complex (Abou-Zeid et al., 1988) indicates that the antigen 85B 
components are associated with the bacterial surface besides 
being the major secreted protein constituent of mycobacterial 
culture fluids. The localization index is an expression of 
secretion efficiency (Wiker et al., 1991) and the antigen 85A 
has higher value than for antigen 85B, indicating that antigen 
85B may be less efficiently secreted and more closely associated 
with the bacterial surface. 
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Autoimmunity and Autoimmune Diseases 
The normal function of the immune system is to discriminate 
between self and non self components and responds to a wide 
variety of foreign or non self antigens (not responds to one's 
own self antigens). However under various kinds of stresses, 
immunological disbalance results to discriminate between 'self 
and 'non-self leading to antibody production against various 
cellular components, resulting in clinical disease (Deodhar, 
1992). The term 'autoimmune disease' refers to a variety of 
illness in which immune processes are directed against the 
self. Thus, autoimmunity can be defined by the presence of 
autoantibodies and/or T cells which react against self antigens 
(Druet, 1992). An autoimmune disease may be organ/tissue 
specific. For example Hashimoto's syndrome, thyrotoxicosis, 
pernicious anaemia or non organ/tissue specific (systemic) such 
as progressive systemic sclerosis (PSS) or systemic lupus 
erythematosus (SLE). 
There is no single theory or mechanism that can 
adequately explain all features of autoimmune diseases. 
However, three models have been proposed for the induction of 
a productive autoimmune process. The first is the autoimmune 
response to a cross-reacting antigen, i.e., crossreactivity 
between host and foreign antigens or modification of host 
proteins due to infection, drug administration, inflammation, 
etc. (Theofilopoulos and Dixon, 1985; Huang et al., 1988). The 
second is a genetic predisposition for autoimmunity through 
regulatory failure, and the third is the triggering with 
bacterial mitogen of potentially autoimmune B cells, normally 
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held in check by suppressor cells. 
Autoimmune diseases shows a highly significant familial 
predisposition (Hochberg, 1987; Arnett, 1992) . The involvement 
of genetic factors has been linked to the human lymphocyte 
antigen (HLA) system, particularly the HLA-DR sublocus. The HLA 
genes function as secondary genes to allow expression of 
specific autoantibody or the respective disease state (Bias 
et al., 1986). In a wide variety of autoimmune disease, 
the regulatory failure results in significant decrease in 
T-suppressor cell numbers and activity, thereby imbalancing the 
T-helper / T-suppressor cell ratio. Hormonal factors as sex 
hormones, thymic hormones, and corticosteroids play a 
significant role so that autoimmune diseases occur more 
commonly in females than they do in males. (Talal, 1989; 
Carlsten et al., 1990; Counihan et al., 1991; Lahita, 1992; 
Moinuddin and Ali, 1994). Polyclonal B cell activation may be 
responsible for the overactivation of B cells and production of 
autoantibodies in certain autoimmune diseases, particularly SLE 
(Dziarski, 1988; Klinman et al., 1990; Steinberg, 1992). In 
autoimmune prone individuals, B cells are hyper-responsive to 
polyclonal activators and undergo initial activation, followed 
by expansion, including expansion of autoreactive clones, under 
the influence of exogenous or endogenous polyclonal activators. 
Of various autoimmune disease, systemic lupus erythematosus 
(SLE) is a prototype autoimmune rheumatic disease (Isenberg and 
Shoenfeld, 1987) characterized serologically by the presence 
of autoantibodies against numerous cellular and macromolecular 
antigens of self and exogenous origin. These autoantibodies have 
14 
specificities for nucleic acids, histones and ribonucleoproteins. 
A central paradox of the pathogenesis of SLE is the origin of 
anti-DNA autoantibodies. 
Native DNA per se is not immunogenic (Karounos et al., 
1988) however, there are numerous reports of DNA modified by 
various agents being potent immunogens, eliciting high titer 
anti-DNA antibodies. These induced antibodies also crossreacts 
with native DNA. For example, DNA modified with psoralen (Hasan 
et al., 1991; Arjumand and Ali, 1994), reactive oxygen species 
(Ara et al., 1992; Alam et al. , 1993; Ara and Ali, 1992 and 
1993), estradiol (Moinuddin and Ali, 1994), DNA-lysine 
photoadduct (Alam et al., 1992), and polylysine-polyglutamate 
complexes (Arif et al., 1994). Although the presence of these 
autoantibodies in SLE is well studied, the mechanisms leading 
to autoantibody production are unknown. T cell dysfunction, 
polyclonal B cell activation (Klinman and Steinberg, 1987), and 
antigen-specific immunization have all been proposed as 
contributors to autoantibody production. 
Recently antibodies to cardiolipin have been shown to 
cross react with DNA. This suggests the possibility that in SLE, 
native DNA may not be the initiating factor for autoimmune 
reactivity, but rather, the pathogenic anti-DNA antibody may be 
an example of immunologic cross-reactivity (Nakamura et al., 
1988; Arif et al., 1994). An important finding to emerge from 
this analysis, is that some anti-DNA antibodies are polyspecific 
and bind antigens distinct from DNA. These include RNA, nuclear 
proteins such as histones and Sm particles, cell surface 
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antigens, cytoskeleton proteins, phospholipids, IgG, and 
bacterial products (Lafer, 1981; Pisetsky, 1984; Rubin, 1984; 
Caroll, 1985; Pisetsky et al., 1985). Thus the mechanism of 
polyspecificity has implications for mechanisms of autoantibody 
production and any of the cross-reactive antigens bound by 
anti-DNA antibodies serve as immunogenic trigger. More 
recently, heat-shock proteins (HSPs) has focussed attention in 
autoimmunity (Polla and Young, 1989). The highly conserved 
sequence between host and a given infectious agent, HSPs, because 
of molecular mimicry, may provide the link between infection and 
subsequent autoimmunity. 
In the present study attempts have been made to probe the 
possible involvement of secreted mycobacterial protein(s) in 
autoantibody induction. Secreted mycobacterial protein antigen(s) 
were isolated from the culture filtrate of Mycobacterium 
tuberculosis (H37Rv) grown on Sauton's medium. Gradient SDS-PAGE 
was employed to monitor the wide array of secreted protein 
antigen(s) in the culture filtrate. The antigen 85 complex from 
Mycobacterium tuberculosis culture filtrate (MTCF) was isolated 
by the gel filtration chromatography. The immunointeraction of 
the aibove isolated secretory protein antigen(s) was assessed by 
ELiSA and Dot blot assay. The binding of immunoaffinity purified 
SLE anti-DNA antibodies with mycobacterial antigen 85 complex was 






Bovine serum albumin, Calf thymus DNA, Coomassie Brilliant 
Blue R 250, agarose, ethidium bromide and anti-human IgG 
alkaline phosphatase conjugate were purchased from Sigma 
Chemical Company, U.S.A. Polystyrene microtitre flat bottom 
ELISA plates having 96 wells (7 mm in diameter) were obtained 
from NUNC, Denmark. Acrylamide, bis-acrylamide, N-N-N'-N' 
tetramethyl ethylenediamine, ammonium persulphate and Tween-20 
were obtained from Bio-Rad Laboratories, U.S.A. Sephadex G-25 and 
Sephadex G-200 as well as ficoll-400 were from Pharmacia Fine 
Chemicals, Sweden. A colorigenic substrate p-nitrophenyl 
phosphate was obtained from C.S.I.R. Centre for Biochemicals, 
New Delhi. 
Asparagine, citric acid, magnesium sulphate, dipotassium 
hydrogen phosphate, ferric ammonium citrate and glycerol were 
obtained from Qualigens, India. Sodium pyruvate was obtained 
from SRL, India. All other chemicals were of highest grade 
available. 
2. Equipment 
ELISA microplate reader MR-600 (Dynatech, U.S.A.), ELICO pH 
meter model Ll-120, Shimadzu spectrophotometer UV-240; 
Gradient former model 385, Protean II xi cell slab gel 
electrophoresis, Trans-Blot electrophoretic transfer cell (Bio-
Rad Laboratories, U.S.A.) and sonicator (Braun-Sonic, Melsunger, 
Germany) were the major equipments used in this study. 
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3. Sera Specimen 
Normal human sera were obtained from healthy subjects. SLE 
sera were obtained from outdoor and indoor patients of the 
Department of Medicine, All India Institute of Medical Sciences, 
New Delhi and J.N. Medical College, A.M.U., Aligarh. The SLE sera 
showed high titer anti-DNA antibodies and fulfilled the American 
College of Rheumatology (formerly American Rheumatism 
Association) revised criteria for the classification of SLE 
(Arnett et al., 1988). Serum samples were decomplemented by 
heating at 56°C for thirty minutes and stored in small 
aliquots at -20°C until use with 0.1 percent sodium azide as 
preservative. 
B. Methods 
1. Determination of Protein Concentration 
Protein was estimated by the method of Lowry et al. (1951) 
as described below 
a) Folin-Ciocalteu reagent 
The reagent was purchased from C.S.I.R. Centre for 
Biochemicals, New Delhi and diluted 1:4 with distilled water 
before use. 
b) Alkaline Copper reagent 
It consists of two components 
(i) 2% sodium carbonate in 0.1 N sodium hydroxide. 
(ii) 0.5% copper sulphate in 1% sodium potassium tartarate. 
The working reagent was prepared fresh before use by 




Freshly prepared 5 ml of alkaline copper reagent was mixed 
with 1 ml of protein sample. After mixing the contents 
thoroughly, the tubes were incubated at room temperature for 
ten minutes. One milliliter of 1:4 times diluted Folin-
Ciocalteu reagent was added with immediate mixing. The tubes were 
left for thirty minutes at room temperature. The absorbance 
was monitored at 660 nm. The protein content of unknown sample 
was determined from standard plot constructed against bovine 
serum albumin (Fig. 1). 
2. Colorimetric estimation of DNA 
The concentration of DNA was estimated colorimetrically 
according to Burton (1956) using diphenylaraine reagent. 
a. Diphenylamine reagent 
750 mg of recrystallized diphenylamine was mixed with 50 
ml of glacial acetic acid and 750 jal of concentrated sulphuric 
acid. The reagent was prepared fresh before use. 
b. Procedure 
One milliliter of DNA solution was mixed with 1.0 ml of IN 
perchloric acid. The sample tubes were incubated for 15 minutes 
in a water bath mantained at 70+l°C. One hundred microlitre 
of 5.43 mM acetaldehyde was added followed by 2.0 ml of 
diphenylamine reagent. The contents were vortexed and incubated 
at room temperature for 16-20 hours. The absorbance was 
recorded at 600 nm and the DNA concentration in unknown sample 
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Figure 1. Standard plot for the colorimetric estimation 
of protein. 
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purified native calf thymus DNA (Fig. 2). 
3. Fluorimetric Assay of DNA 
Fluorimetric estimation of DNA was carried out according to 
Lebarca and Paigen (1979) using Hoechst dye. The dye 
Hoechst [C2-[2-(4 hydroxyphenol)-6-benzimida2olyl-6 (1- methyl-4-
piperazyl) benzimidazole] interacts with DNA with a many fold 
increase in fluorescence. 
a. Reagents 
(i) 0.05M sodium phosphate (pH7.4) containing 0.002M EDTA and 
2M sodium chloride, 
(ii) 200 jag/ml of Hoechst 32258 in deionized water. 
The working dye solution was prepared fresh before use by 
diluting (ii) 200-fold in solution (i). 
b. Method 
DNA solution of varying concentrations (0.1-1.0 ng) in a 
final volume of 0.1 ml was mixed with 2.4 ml of working dye 
solution. The mixture was incubated for 5 minutes at room 
temperature and the fluorescence was monitored at 460 nm 
( Agx=355 nm). The fluorescence of a solution containing dye 
along with buffer, but devoid of DNA, was taken as control. 
4. Isolation of SLE IgG by Protein A-Sepharose 
Commercially available Protein A - Sepharose CL-4B (1.5 
gm) was swelled in 0.01 M phosphate buffered saline (PBS), pH 
7.4 at room temperature for 72 hrs. The swelled gel (about 
5.0 ml) was washed with PBS and subsequently packed through 
gravity sedimentation onto a column measuring 0.9 cm x 15 cm. 
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Figure 2. Standard plot for the colorimetric estimation of 
DNA. 
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The column was washed once with 0.1 M sodium-citrate, pH 3.0, to 
elute any bound material and then equilibrated with five volumes 
of PBS (pH 7.4). Serum diluted with an equal volume of PBS was 
loaded onto the column and was allowed to bind at a rate of 
about 20 ml/hr. The binding of IgG molecule to protein A-
Sepharose occurs through its Fc fragment/regions. The unbound 
proteins were eliminated with PBS and the absorbance of the 
effluent was monitored till a negative absorbance at 280 nm was 
obtained. The bound IgG was eluted with 0.58% acetic acid in 
0.85% sodium chloride (Coding, 1976). To prevent the effect of 
acidic elution buffer on IgG, the eluate was collected in IM 
Tris-HCl, pH 8.5. Fractions containing IgG was read at 280 nm 
(Fig. 3) and concentration was determined considering 14 
O.D23o=10 mg IgG/ml. 
5. Iinmunoaffinity Purification of SLE IgG on DNA- [polylysyl-
Sepharose 4B] column 
a. CNBr activation of Sepharose 4B 
Fifteen milliliter of Sepharose 4B was suspended in 
distilled water, filtered and washed with 300 ml of cold 
distilled water on a sintered glass funnel (porosity G-2). 
Approximately 10 gm of moist gel in 10 ml of 2 M sodium 
carbonate was kept in an ice-NaCl bath and placed on magnetic 
stirrer. One gram cyanogen bromide in 0.8 ml acetonitrile was 
slowly added to the gel with gentle stirring. After twelve 
minutes, the reaction product was filtered on sintered glass 
funnel, washed with 400 ml of cold 0.1 M sodium bicarbonate 

















2 A 6 
FRACTION NUMBER 
Figure 3. Elution profile of SLE IgG by Protien 
A-Sepharose column. High titer anti-DNA 
antibody was applied onto the column and 
bound material was eluted with 0.58% 
acetic acid in 0.85% sodium chloride. 
Fractions of 3 ml each was collected in 
a measuring cylinder containing 1 ml of 
IM Tris-HCl, pH 8.5. 
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The unreacted CNBr (drained effluent) was reacted with ferrous 
sulphate to convert it into harmless ferrocyanide. All steps 
were carried out in a fume-hood chamber (Ali, 1984) . 
b. Poly-L-lysine coupling to activated Sepharose 4B 
The method described by Wilchek (1973) was followed. 
Immediately after CNBr activation of gel, equal volume of poly-L-
lysine (100 mg in 10 ml of 0.1 M sodium carbonate) was added and 
the reaction was allowed to proceed at 4°C for 12 hr with slow 
stirring. The buffer was drained out and the gel was washed 
successively with 100 ml each of cold (i) distilled water (ii) 
O.IN HCl (iii) 0.IM sodium bicarbonate and (iv) distilled water 
till neutral. Finally, the gel was suspended in 40 ml of 0.15 M 
acetate buffer, pH 4.5. The extent of poly-L-lysine depletion 
due to covalent coupling with activated Sepharose 4B was 
quantified by the treatment of drained effluent with TNBS as 
described by Habeeb (1966) . 
c. Innnunoaffinity purification of anti-DNA antibodies 
DNA-[polylysyl-Sepharose 4B] affinity column was prepared 
according to method described earlier (Nikotra et al., 1982) with 
slight modifications. Twenty milliliter of swelled polylysyl-
Sepharose 4B gel was packed through gravity sedimentation, in a 
glass radni column, measuring 1.6 cm x 5 cm and equilibrated with 
0.15M acetate buffer, pH 4.5. Purified DNA (12.5 ml of 100 ug/ml 
in acetate buffer) was loaded onto the column and unbound 
material was washed out with 50 ml of PBS, pH 7.4. Heat 
decomplemented SLE serum, dialyzed against PBS, pH 7.4 was 
diluted 1:10 and passed through column. The unbound antibodies 
were washed with PBS and bound proteins were eluted with 
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linear ionic strength gradient of 0.15-3.0 M sodium chloride in 
0.01 M phosphate buffer, pH 7.4. Fractions of 3 ml were 
collected and the contents of each tube were monitored at 251 
nm, 260 nm, 278 nm and 280 nm. (Fig. 4). 
d. Regeneration of affinity coliimn 
The same column was regenerated several times by washing 
successively with 50 ml each of the following : (i) distilled 
water (ii) 0.IN HCl (iii) 0.IM sodium carbonate and (iv) 
distilled water till neutral. 
6. Gel Electrophoresis 
(a) Polyacrylamide slab gel electrophoresis for proteins 
Polyacrylamide slab gel electrophoresis was performed under 
denaturing conditions as described by Laemmli (1970). The 
following stock solutions were prepared : 
(i) Acryleunide-bisacrylamide (30:0.8) 
Thirty gram acrylamide and 0.8 gm bisacrylamide was 
dissolved in a total volume of 100 ml of distilled water. The 
solution was filtered and stored at 4°C in an amber colored 
bottle in order to prevent photopolymerization. 
(ii) Resolving gel buffer, 3 M Tris-HCl (pH 8.8) 
36.3 gm Tris was dissolved in 48.0 ml of IN HCl, pH adjusted 
to 8.8 and the final volume brought to 100 ml. 
(iii)Stacking gel buffer, 0.5 M Tris-HCl (pH 6.8) 
6.05 gm Tris was dissolved in 40 ml distilled water, 
titrated to pH 6.8 with IN HCl and the final volume adjusted to 
100 ml with distilled water. 
(iv) Electrode buffer 
0.02 M Tris and 0.192 M glycine, pH 8.3 containing 0.1% SDS. 
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FRACTION NUMBER 
Figure 4. Irranunoaffinity purification of anti-DNA 
antibody on DNA-[polylysyl-Sepharose 4B] 
column. Anti-DNA positive SLE serum was 
passed through the column and bound 
material was eluted with linear gradient 
( ) of sodium chloride (0.15 to 3 M) 
in 0.01 M Na-Pi buffer, pH 7.4. 
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(v) Sample buffer 
a. Six gram Tris was dissolved in 80 ml distilled water 
and the pH was adjusted to 6.8 with 0-phosphoric acid. 
The final volume was brought to 100 ml. 
b. To 12.5 ml of above solution was added 1 mg bromophenol 
blue and 12.5 ml glycerol. B-mercaptoethanol was added just 
before use. 
One part of (b) and four part of sample were mixed and 
boiled for five minutes just before electrophoresis. 
The resigents were mixed in the order shown and poured into 
the gradient former. 20-5% gradient gel was formed from bottom 
to top between two glass plates separated by 1 mm thick spacer. 
The gel was allowed to polymerize at room temperature. The 
samples were electrophoresed for 8-10 hr at room temperature 
at 80 volts. The gel was stained by 0.2% Coomassie Brilliant 
Blue R 250 or with silver stain reagent (Merril et al., 1983). 
RECIPE FOR 5 - 20 % GRADIENT GEL 
(Total volume 24 ml) 
Solution 5% Resolving gel 2 0% Resolving gel 
Acrylamide-
8 ml 
1 .5 ml 
120 jLil 
600 u l 
1 .78 ml 
6 nl 
bisacrylamide 
Resolving gel buffer 
10% SDS 




: 2 ml 
: 1.5 ml 
: 12 0 Ul 
: 600 Ul 
: 7.78 ml 
: 6 ul 
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RECIPE FOR 2.5 % STACKING GEL 
(Total Volume 10 ml) 
Acrylamide-bisacrylamide : 1.25 ml 
Stacking gel buffer : 2.5 ml 
10% SDS : 100 jul 
1.5% Ammonium persulphate : 500 jal 
Distilled water : . 5.65 ml 
TEMED : 7 .5 jal 
(b) Agarose gel electrophoresis of DNA 
Thirty milliliter of 1% agarose was brought in the molten 
state in electrophoresis buffer (0.04 M Tris acetate, pH 8.0 
containing 0.002 M EDTA) and was allowed to cool till 50-60°C. 
Subsequently, it was poured on horizontal gel tray (sealed from 
both the sides) and was allowed to solidify for 30-60 min at room 
temperature. The DNA samples were applied into the wells and 
electrophoresed for 2-4 hr at 30 mA in a tank filled with the 
same buffer. On completion of electrophoresis, gels were stained 
with ethidium bromide and visualized under UV illumination and 
photographed. 
7. Immxinological detection of anti-DNA antibodies 
Anti-DNA antibodies were evaluated by using purified calf 
thymus DNA as antigen. The techniques used were immunodiffusion, 
counter immunoelectrophoresis and Enzyme linked-immunosorbent 
assay. 
a. Immunodifusion (ID) 
Immunodiffusion was carried out by Ouchterlony double 
diffusion system using glass petridishes as described by Tan et 
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al., (1966). Six milliliter of 0.4% agarose solution in PBS, pH 
7.4 was brought into molten state, allowed to cool to 50-60°C 
and subsequently poured into 5 cm x 1.5 cm glass petridishes. 
Wells each 5 mm in diameter and separated by 8 mm distance were 
cut into hardened agarose gel. Appropriate concentration of 
antibody (serum) and antigen was placed in the wells and the 
reaction was allowed to proceed for 48-72 hours in a moist 
chamber at room temperature. The gels were washed with 5 % 
sodium citrate to remove non-specific precipitin lines. The 
precipitin lines were analyzed visually and photographed. 
b. Counter immunoelectrophoresis (CIE) 
CIE was performed as described by Kurata and Tan (1976) 
with slight modifications. Three milliliter of 0.6% molten 
agarose solution in 25mM barbital buffer, pH 8.4 was poured 
onto microscopic slides (7.5cm x 2.5cm) and allowed to solidify 
at room temperature. Wells, 4mm in diameter were cut at a 
distance of 5mm between the two opposite wells. Antigen (nucleic 
acid or protein in PBS, pH 7.4) was placed in cathodal well and 
antibodies (decomplemented sera or IgG) in the anodal well. The 
sample loaded agarose slides were electrophoresed for 45-60 
minutes in 50 mM barbital buffer, pH 8.4 with a current of 3-4 mA 
per slide. Non-specific precipitin lines were removed by washing 
with 5% sodium citrate. 
c. Enzyme Linked - Immunosorbent Assay (ELISA) 
The antibodies were detected and quantitated by ELISA 
using polystyrene flat bottom microtiter plates as solid phase. 
The method described by Ali et al. (1985) and Arif et al. (1994) 
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were followed for the assay. 
a) Buffers and substrate 
(i) Tris buffered saline (TBS), pH 7.4 : 
10 mM Tris, 150 mM NaCl, pH 7 .4 
(ii) Tris buffered saline Tween-20 (TBS-T), pH 7.4 : 
20 mM Tris, 144 mM NaCl, 2.68 mM KCl and 500 Jul Tween-20, 
pH 7.4 
(iii)Bicarbonate buffer, pH 9.6 : 
15 mM sodium carbonate, 35 mM sodium bicarbonate, pH 9.6 
(iv) Substrate buffer, pH 9.6 : 
15 mM sodium carbonate, 35 mM sodium bicarbonate and 2 mM 
magnesium chloride, pH 9.6 
(v) Substrate : 
500 jug/ml of p-nitrophenyl phosphate in substrate buffer. 
b) Procedure 
Polystyrene microtiter plates were incubated with 100 jal of 
protein antigen (50 ug/ml in carbonate/bicarbonate buffer, pH 
9.6) for two hours at room temperature followed by overnight 
incubation at 4°C. The plates were washed thrice with TBS-T and 
the unoccupied sites were blocked by 150 jul of 1.5% BSA in TBS 
for six hours at room temperature. Varying dilutions of sera 
diluted in TBS were added to antigen coated as well as control 
wells. The antigen-antibody interaction was allowed to proceed 
for two hours at room temperature followed by overnight 
incubation at 4°C and subsequently, the plates were washed four 
times with TBS-T in order to remove the uninteracted 
antibodies. Bound antibodies were assayed with an 
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appropriate anti-immunoglobulin alkaline phosphatase conjugate 
using p-nitrophenyl phosphate as substrate. The absorbance of 
each well was monitored at 410 nm on an ELISA microplate reader 
after proper color development. Each sample was coated in 
duplicate and the results were expressed as a mean of A^ .gg^ -
A 
control• 
For nucleic acid antigens, the polystyrene microtiter 
plates were preincubated with 100 yl of poly D-lysine solution 
(50 jug/ml in distilled water) for half an hour so as to increase 
antigen immobilization. The plates were washed thrice with TBS 
and coated with 100 jul of nucleic acid antigen (s) at a 
concentration of 2.5 jug/ml in TBS for two hours at room 
temperature followed by overnight incubation at 4'-'C. After 
eliminating the unbound antigen by washing with TBS-T (3 
times), the unoccupied positively charged polylysine molecules 
were neutralized by saturating the plates with 100 JJI of 
negatively charged poly L-glutamate (50 jug/ml in TBS) for two 
hours at room temperature. The rest of the steps were same as 
described above. 
c) Inhibition ELISA 
The antigen binding specificity of antibody was determined 
by inhibition experiments (Hasan et al, 1991). Varying 
concentration of inhibitors (0-15 jug/ml) were mixed with a 
constant amount of antiserum. The mixture was incubated for two 
hours at 37°C followed by overnight incubation at 4°C. The 
resulting immune complex was coated onto the wells instead of 
serum. The rest of the steps were as in direct binding ELISA. 
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8. Isolation of Mycobacterial antigen 
a. Organism 
Mycobacterium tuberculosis H37Rv strain was obtained from 
All India Institute of Medical Sciences, New Delhi by passage on 
Lowenstein-Jensen medium. The organisms were grown in modified 
Sauton's liquid medium. The composition of modified Sauton's 
medium, is as follows : 
Asparagine 4.0 gm 
Citric acid 2.0 gm 
Magnesium sulphate 0 . 5 gm 
Dipotassium-hydrogen phosphate 0.5 gm 
Ferric ammonium citrate 0.05 gm 
Glycerol 3 5 ml 
Sodium pyruvate 5 gm 
Distilled water to make 1 litre 
The pH was adjusted to 7.4 by addition of dilute ammonium 
hydroxide solution and autoclaved at 120°C for 30 minutes. 
Cultures were grown at 37°C for 10-12 days. 
b. Procedure 
Young mycobacterial cultures were heat killed at 100°C for 
one hour in a boiling water bath. The cultures were centrifuged 
at 10,000 rpm for thirty minutes at 4°C. The filtrate was 
separated from the pellets. The culture filtrate containing 
secreted proteins were stored at -20°C until further use. 
c. Desalting of Mycobacterium tuberculosis culture filtrate 
(MTCF) protein(s) 
The supernatant fluid was sterlized by filtration through a 
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0.45;am pore-size membrane (Millipore Corp. ,U.S .A.) . Mycobacterium 
tuberculosis culture filtrate (MTCF) was concentrated fifty fold 
and passed through gel filtration PD-10 column {containing 
Sephadex G-25) for desalting. The protein content was determined 
by the method of Lowry et al. (1951) against a bovine serum 
albumin (BSA) standard. The culture filtrate preparations were 
stored in small aliquots at -20°C. 
d. Mycobacterium txiberculosis sonic extract (MTSE) proteins 
The heat killed bacilli were washed with sterile Tris-
buffered saline, pH 7.4 (TBS) and suspended in sonicating 
buffer containing 1.0 mM DTT, 1.0 mM PMSF and p-mercaptoethanol 
in Tris-buffered saline, pH 7.4. The cell suspension was 
disrupted by sonicating at 4°C for 10 minutes and the cell 
debris was removed by ultra centrifugation at 20000 g for 30 
min. The protein content was determined by the method of Lowry 
et al. (1951) against bovine serum albumin (BSA) as standard. 
The sonic extract preparations were stored at -20°C until 
required in small aliquots. 
e. Fractionation of culture filtrate proteins by gel 
filtration 
The mycobacterial secretory proteins in the culture filtrate 
were fractionated by Sephadex G-200 gel filtration 
chromatography. The column was equilibrated with phosphate 
buffered saline, pH 7.2 (15 mM sodium phosphate, 150 mM sodium 
chloride) containing 0.05% phenylmethylsulphonyl fluoride 
(PMSF), and samples were eluted subsequently with the same 
buffer. Fractions of 2 ml each were collected at a flow rate of 
10 ml/hr. Each fraction of the eluate was analyzed by gradient 
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SDS-PAGE (5-20%). 
f. Gradient SDS - PAGE 
Proteins in culture filtrate were resolved by SDS-PAGE 
using a discontinuous buffer system (Laemmli, 1970) under 
reducing conditions on slab gels of a 5-20% acrylamide gradient 
and visualized by staining with Coomassie Brilliant Blue R-250 or 
with a silver stain reagent. 
g. Western blotting 
The electrophoresed mycobacterial proteins on 5-20% 
acrylamide gradient gel were electro-transferred onto a 
nitrocellulose (NC) membrane for 8-10 hrs at 30 volts. Transfer 
of proteins to NC membrane was ascertained by staining with 0.1% 
amido black 10-B. The unstained nitrocellulose membranes were 
soaked in 1% (w/v) BSA in TBS-T to block any free protein -
binding sites. After blocking, nitrocellulose strips were 
incubated with high titre SLE sera (1:100 diluted ) in 1% BSA 
in TBS-T at room temperature for 2 hr and overnight at 4°C and 
probed, respectively, with anti-human IgG (^ -chain specific) 
peroxidase conjugate (Sigma Immuno chemicals, U.S.A.) 
diluted 1:1000, in 1% BSA in TBS-T for 2 hr at room temperature. 
After washing with TBS-T, the immunoblots were treated with 4 
chloro -1- naphthol (in methanol) in TBS, pH 7.4 in the presence 
of 0.2% H2O2. After 5 minutes, the membrane were washed 
thoroughly in deionized water and dried. 
h. Dot blot Assay 
The culture filtrate and sonic extract was spotted on 
nitrocellulose membrane and air dried. Unoccupied sites were 
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blocked by soaking the NC membrane in 1% BSA in TBS-T. After 
blocking, the membrane was incubated with high titre SLE sera 
(1:100 diluted) in 1% BSA in TBS-T for 2 hours at room 
temperature and overnight at 4°C. Uninteracted antibodies were 
removed by washing with TBS-T and bound antibodies were assayed 
with an appropriate anti-human IgG peroxidase conjugate using 4-




The binding of naturally occurring SLE autoantibodies with 
a variety of antigens, ranging from native DNA to mycobacterial 
protein antigen(s) was probed by employing techniques such as 
ELISA, Western blot and Dot blot assay. Prior to the 
investigation, several SLE sera were tested for their anti-DNA 
antibody titer. Only those sera exhibiting an anti-DNA 
antibody titer of ^ 1:6400 (Fig.5) were selected for reactivity 
with mycobacterial antigens. These above selected SLE sera were 
found to possess non-precipitating anti-DNA antibodies as 
revealed by CIE and ID. Apart from recognizing native double 
stranded DNA, these SLE autoantibodies exhibited a wide spectrum 
in its polyreactivity. Direct binding ELISA on plates coated 
separately with intracellular and secreted mycobacterial proteins 
showed an anti-DNA antibody titer of greater than 1:12800 (Figs. 
6 and 7). However, normal human sera did not show any appreciable 
binding. The results indicated higher reactivity of SLE 
autoantibodies towards mycobacterial protein antigen(s) than with 
native double stranded DNA. 
In view of the above binding results attempts were also made 
to ascertain whether these autoantibodies were exhibiting 
reactivity exclusively towards secreted mycobacterial proteins or 
towards contaminations of mycobacterial DNA in mycobacterium 
tuberculosis culture filtrate (MTCF) due to possible leakage of 
DNA from the ruptured bacilli. Thus, fluorimetric as well as 
colorimetric estimations for DNA was carried out. The results 
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Fig^ ire 5. Direct binding ELISA of SLE serum. The 
microtiter plates were coated with 
native DNA (2.5ug/ml). 
(—O— ) SLE serum l 
( % ) SLE serum 2 
i~^—) SLE serum 3 
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Figure 6. Direct binding ELISA of SLE serum. The microtiter 
plate was coated with intracellular mycobacterial 
proteins (50 ug /ml). 
) SLE serum 
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Figure 7. Direct 
plates 
proteins (50 jug/ml) . 
(—O—) SLE serum 1 
(—A— ) SLE serum 2 
(—•—) SLE serum 3 
(i—©—) Normal human sera 
binding ELISA of SLE serum. The microtiter 
were coated with the secreted mycobacterial 
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proteins and had no contaminations of DNA. Therefore, the 
observed binding of anti-DNA antibodies was only due to the 
presence of secretory proteins. Furthermore, in order to 
substantiate the above result, agarose gel electrophoresis was 
carried out to detect mycobacterial DNA. Thus, both culture 
filtrate (MTCF) as well as total mycobacterial sonicate were 
subjected to electrophoresis. Only samples of total 
mycobacterial sonicate showed DNA bands in the electrophoresed 
gel. No DNA was detected in MTCF (Fig.8). 
After ascertaining that anti-DNA antibodies in SLE sera 
reacted exclusively with secreted mycobacterial proteins, 
studies were also perfoirmed with Protein-A Sepharose isolated SLE 
IgG. As evident from Figure 9, the binding results were 
similar with the one obtained with SLE serum. 
Competition inhibition ELISA was employed in order to 
ascertain the specificity of these SLE autoantibodies against 
various nucleic acid and mycobacterial inhibitors. The 
inhibitors employed were double stranded DNA, heat denatured DNA, 
RNA, secretory proteins in culture filtrate (MTCF) and 
intracellular proteins in sonic extracts (MTSE). As illustrated 
in Figure 10, native double stranded DNA exhibited maximum 
inhibition in the antibody binding to the extent of 70 percent, 
at a maximum inhibitor concentration of 10 jag/ml. Fifty percent 
elimination in the antibody binding was recorded at an inhibitor 
concentration of 2 .6 ug/ml. Nearly the same magnitude of maximum 
inhibition in antibody binding was observed with single stranded 
DNA. However, fifty percent inhibition in the antibody binding 
was found to occur at a much lower inhibitor concentration (l.O 
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Figure 8. Agarose gel electrophoresis of total 







mycobacterial culture filtrate 
(MTCF) 
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Figure 9. Direct binding ELISA of Protein A-Sepharose 
isolated SLE IgG. The microtiter plate was 
coated with secreted mycobacterial proteins 
(50 Mg/ml). 
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Figure 10. Inhibition ELISA of SLE anti-DNA antibodies. 
The microtiter plates were coated with native 
DNA (2.5 iig/ml) . The competitors were native 
DNA ( — O — ) , heat denatured DNA ( — • — ) , and 
RNA (—«— ) . 
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jug/ml). Moreover, no binding was observed with RNA. In this case 
only 6.5 percent inhibition was achieved at a maximum inhibitor 
concentration of 15 jug/ml (Fig. 10) . 
On the other hand, in inhibition ELISA, the binding of SLE 
autoantibodies to both secretory and intracellular mycobacterial 
protein antigen(s) were of very high magnitude as compared to 
native DNA. Out of the various SLE sera tested, three of them 
having high titer anti-DNA antibodies were selected for 
inhibition studies with secretory proteins. As evident from the 
binding results, a maximum of 91 percent inhibition in the 
antibody binding was recorded at an inhibitor concentration of 20 
ug/ml (Fig.11). The fifty percent elimination in the antibody 
binding of various SLE sera by secretory protein in culture 
filtrate required inhibitor concentration in the range of 0.7 
ug/ml to 2.2 jug/ml (Fig.11). However, when inhibition ELISA was 
performed with Protein-A Sepharose isolated SLE IgG, a maximum 
of 89 percent inhibition was observed at an inhibitor 
concentration of 20 ug/ml (Fig.12). In this case, fifty percent 
elimination in the antibody activity was achieved with a very 
low inhibitor concentration (0.005 ug/ml). Judged on the basis 
of fifty percent inhibition, the results indicate the presence 
of highly specific autoantibodies in SLE sera for secretory 
proteins of Mycobacterium tuberculosis (H37Rv). The binding 
characteristics of various nucleic acid and mycobacterial 
inhibitors with SLE autoantibodies (both serum and isolated SLE 
IgG) are depicted in Table 1. 
The 5-20% gradient SDS-PAGE performed for secreted 
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INHIBITOR CONCENTRATION (jug/m« ) 
Figure 11. Inhibition of SLE anti-DNA antibody binding 
by secreted mycobacterial proteins. The 
microtiter plates were coated with secreted 
mycobacterial proteins (50 ng/ m l ) . 
( A ) SLE serum 1 
(—•—) SLE serum 2 




Figiare 12. Competition immunoassay of Protein A-
Sepharose isolated SLE IgG (25 ug/ml) binding 
by secreted mycobacterial proteins. The 
microtiter plate was coated with secreted 
mycobacterial proteins (50 jug/ml) . 
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SLE IgG MTCF 0-20 0.005 89 
48 
mycobacterial proteins (MTCF) showed protein antigens of both 
low and high molecular weights (Fig. 13). The culture filtrate 
proteins were fractionated by employing Sephadex G-200 column 
chromaitography (Fig. 14). The peak fractions of the chromatogram 
(fraction 6 and 7) were subjected to gradient SDS-PAGE (Fig.15). 
The electrophoresed gel of fractions 6 and 7 indicated 
mycobacterial protein antigens of molecular weights 3 0KDa 
and 31KDa, which ultimately corresponded to the antigen 85 
complex of Mycobacterium tuberculosis. The isolated antigen 85 
complex was in turn subjected to binding studies with SLE anti-
DNA antibodies. Direct binding ELISA on plates coated with 
mycobacterial antigen 85 complex exhibited a binding of very 
high magnitude with SLE autoantibodies, when compared with the 
binding results of DNA and total mycobacterial culture filtrate 
(MTCF). The antibody titer in this case was found to be greater 
than 1:12800 (Fig.16). The results thus indicate that antigen 85 
complex was probably providing the major immune-dominant 
epitope(s) for SLE anti-DNA autoantibody binding. 
In order to further strengthen the obtained binding 
results, the SLE autoantibodies were subjected to immuno-
affinity purification on a DNA-polylysyl-Sepharose 4B column. 
The immunoaffinity purified SLE IgG (anti-DNA antibodies) was 
used for binding studies. Western blot of antigen 85 complex 
with immunoaffinity purified SLE IgG exhibited a strong antigen-
antibody interaction (Fig.17). The Western blot results further 
substantiates the above binding results probed by ELISA. 
Additional evidence for the recognition of mycobacterial 
secretory proteins by SLE anti-DNA autoantibodies was 
49 
I 2-
Figure 13. SDS-PAGE of secreted mycobacterial 
proteins on 5-20% gradient gel. 
Lane 1 : marker 


















5 10 15 20 
FRACTION NUMBER 
Figure 14. Fractionation of mycobacterial culture 
filtrate proteins on Sephadex G-200 
column. Fractions of 2 ml each was 
collected and the protein content of 
each tube was monitored by the method 
of Lowry et al. 
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Figure 15. SDS - PAGE of fractionated secreted 
mycobacterial proteins on 5 - 20 % 
gradient gel. 
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2.6 2.9 3.2 3.5 
-LOG SERUM DILUTION 
3.8 4.2 
Figure 16. Direct binding ELISA of SLE serum. 
The microtiter plate was coated with 
mycobacterial antigen 85 complex (50 
jug/ml) . 
(—O— ) SLE serum 
( — # — ) Normal human sera 
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i'-;'< 
Figure 17. Western blotting of mycobacterial 
antigen 85 complex with affinity-
purified SLE IgG exhibiting a strong 
antigen-antibody interaction. 
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ascer ta ined by Dot blot immunoassay, performed on n i t roce l lu lose 
membrane. A d i s t i n c t spot obtained on n i t r o c e l l u l o s e membrane 
(Fig. 18) as a consequence of antigen-antibody in te rac t ion 
further subs t an t i a t e s the above r e s u l t s . 
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Figure 18. Dot b lo t of SLE anti-DNA autoant ibodies 
binding by mycobacterial secre tory 




Circulating autoantibodies against native double stranded 
DNA have been found in sera of patients with autoimmune disorders 
(Stollar, 1986). The antibody is most prevalent in patients 
with systemic lupus erythematosus (SLE) where its titer has 
been correlated with clinical manifestations (Pollard et 
al.,1986; Arnett et al., 1988). The basic questions on the 
origin of anti-DNA antibodies in SLE and other autoimmune 
diseases has not been answered. However, recent studies point 
out that native DNA might actually be a cross reacting antigen 
whereas some other structure stimulates the antibody response. 
These structures include DNA- estradiol conjugate (Moinuddin and 
Ali, 1994) , DNA-psoralen crosslink (Arjumand and Ali, 1994) , 
polylysine-polyglutamate complex (Arif et al., 1994), ROS-DNA 
(Ara and Ali, 1993), DNA-RNA hybrids (Rich et al.,1984), 
phospholipids (Smeenk et al., 1987), DNA-lysine photoadduct (Alam 
et al.,1992) and Z-DNA (Hasan and Ali, 1990). Native DNA is no 
longer regarded as the antigen initiating the disease mainly 
because immunization with native DNA does not induce symptoms 
like SLE. 
Recent studies indicate the possible involvement of some 
mycobacterial protein antigens acting as trigger for 
autoantibody production (Norten et al., 1989; Cohen and Young, 
1991; Winfield and Jarjour, 1991) . Some studies suggest that 
protein antigens present in Mycobacterium tuberculosis and 
Mycobacterium leprae may serve as potential immunogens when 
introduced in a suitable manner into the host (Young et al., 
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1985) . Live mycobacteria presumably release such antigens into 
the tissues, inducing both tuberculin hypersensitivity and 
acquired anti-tuberculous resistance (Collins, 1983). Although 
dead mycobacteria may possess the same antigen(s), they induce 
predominantly humoral responses due to excessive release of 
polysaccharide cell wall antigens as the mycobacterial cells 
are digested by the macrophages (Mackaness et al., 1974; 
Collins, 1983). 
In the present study, attempts were made to probe the 
possible involvement of some secreted mycobacterial protein 
antigen(s) in the autoantibody induction. Assay of anti-DNA 
antibodies in the sera of patients with SLE was carried 
out by employing enzyme linked immunosorbent assay. The 
immunointeraction of mycobacterial protein antigens with SLE 
anti-DNA autoantibodies was investigated by means of ELISA, 
Dot blot assay and Western blotting. 
A high titer of anti-DNA antibodies was detected by the 
direct binding method. The autoantibody recognized appreciably 
both native DNA as well as ssDNA, but as judged by fifty percent 
inhibition, values were found to be 2.6 fold more specific for 
ssDNA than for native dsDNA. The binding results thereby is 
suggestive for the presence of a greater magnitude of secondary 
structure specific antibodies in the opted SLE sera. However, 
the selected SLE sera possess backbone specific antibodies but 
were less prevalent than secondary structure specific 
revealed by inhibition studies. 
Surprisingly, as revealed by inhibition -
of greater magnitude was ol^^^t^'f^^'Sitpr-^ SLE autoa 
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the secreted mycobacterial proteins (MTCF) in. comparison to 
native DNA and ssDNA. Comparative analysis of the data on 
studies carried out with serum indicated the specificity of SLE 
autoantibodies in the order of MTCF > ssDNA > dsDNA. 
Furthermore, on assuming the relative affinity of native DNA for 
the binding of anti-DNA antibodies to be 100 percent, the 
mycobacterial secreted proteins (MTCF) showed an affinity of 
around 371 percent with one of the SLE sera. Since the major 
immunodominant secretory protein in mycobacterium tuberculosis 
culture filtrate (MTCF) is the antigen 85 complex, thus attempts 
were made to ascertain its binding with SLE autoantibodies. The 
binding results exhibited recognition of very high magnitude 
(titer > 1:12800) suggesting that the antigen 85 complex was 
probably providing the major immunodominant epitope(s) for SLE 
anti-DNA antibody binding. Further evidence for the strong 
recognition was accomplished by using SLE IgG affinity purified 
on DNA-polylysyl-Sepharose 4B column in the binding studies. The 
immunoaff inity purified SLE IgG was immunointeracted with 
mycobacterial antigen 85 complex previously transferred onto a 
nitrocellulose membrane from the gel. The interaction results 
obtained in Western blotting exhibited a strong recognition of 
these affinity purified SLE IgG by the antigen 85 complex. Thus, 
the VJestern blot results obtained with affinity purified SLE IgG 
(on DNA-matrix) further substantiates for the antigen 85 
complex as an alternate autoantigen or trigger in the production 
of anti-DNA autoantibodies. 
It could be inferred from the above studies that secreted 
mycobacterium tuberculosis protein antigens, particularly the 
59 
antigen 85 complex comprising of 30KDa and 31KDa protein 
antigens, may possibly act as a trigger in autoantibody 
induction. The susceptibility of mankind to mycobacterial 
agents, such as, Mycobacterium tuberculosis (H37Rv) is well 
established. The infected host, in turn, may get accumulated 
with an array of released secretory proteins. Thus, the 
possibility of some low molecular weight secretory proteins 
released in the host acting as a stimuli in autoantibody 
induction could not be ruled out. Our preliminary investigations 
is supportive for the above argument. Thus, the role of low 
molecular weight mycobacterial protein antigen(s) in autoimmune 
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